Motor behavioural function for histamine-dopamine interaction in brain.
Onodera
K
K
Department of Pharmacology, Tohoku University School of Dentistry, Sendai, Japan.
Itoh
C
C
Sato
M
M
Watanabe
T
T
D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D052160:Benzothiazoles; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D015259:Dopamine Agents / Q000494:pharmacology*; D018492:Dopamine Antagonists / Q000494:pharmacology; D006632:Histamine / Q000378:metabolism*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D006639:Histidine / Q000494:pharmacology; D008694:Methamphetamine / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects*; D050198:Phenoxypropanolamines; D010880:Piperidines / Q000494:pharmacology; D011738:Pyrilamine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013239:Stereotyped Behavior / Q000187:drug effects*; D013844:Thiazoles / Q000494:pharmacology
D001552:Benzazepines; D052160:Benzothiazoles; D000697:Central Nervous System Stimulants; D015259:Dopamine Agents; D018492:Dopamine Antagonists; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D050198:Phenoxypropanolamines; D010880:Piperidines; D013844:Thiazoles; D008694:Methamphetamine; D006639:Histidine; D006632:Histamine; D011738:Pyrilamine; C055302:zolantidine